ZOMEDICA CORP

Item 5.07 Submission of Matters to a Vote of Security Holders. An annual meeting of our shareholders was held on June 10, 2026 (the “Annual Meeting”). At the Annual Meeting, our shareholders voted on each of the following three matters: Proposal 1: Election of eight directors, each for a one-year term; Proposal 2: Ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for 2026; Proposal 3: An advisory vote to approve the compensation of our named executive officers as described in our management information circular and proxy statement for the Annual Meeting; and Proposal 4:. An amendment to the By-Laws of the Company to address the quorum requirements for an adjourned meeting of Shareholders as described in the our management information circular and proxy statement for the Annual Meeting. According to the final vote, the Company’s stockholders approved proposals 1, 2 and 4 and did not approve proposal 3. The final vote results for each of these four matters is set forth below. Proposal 1: Election of Eight Directors For Withheld Broker Non-Vote ────────────────────────────────────────────────────────────────────────── Jeffrey Rowe 148,970,700 80,211,388 200,401,611 Robert Cohen 141,153,095 88,028,993 200,401,611 Chris Macleod 141,041,101 88,140,987 200,401,611 Pam Nichols 146,791,443 82,390,645 200,401,611 Johnny D. Powers 151,457,102 77,724,986 200,401,611 Sean Whelan 141,437,085 87,745,003 200,401,611 Rodney Williams 141,615,934 87,566,154 200,401,611 Larry Heaton 148,997,578 80,184,510 200,401,611 Accordingly, stockholders elected all director nominees to hold office for terms expiring at the Company’s 2027 annual meeting of stockholders. Proposal 2: Ratification of Independent Auditors For: 403,285,558 Withheld: 26,298,141 Accordingly, stockholders ratified the appointment of Grant Thornton, LLP as our independent registered public accounting firm for the fiscal year ended December 31, 2026. Proposal 3: Advisory Vote on the Company’s Executive Compensation The votes cast on the advisory vote to approve the compensation of our named executive officers disclosed in our management information circular and proxy statement for the Annual Meeting were as follows: For: 99,891,977 Against: 129,290,109 Broker Non-Vote 200,401,613 Accordingly, stockholders failed to approve, on a non-binding advisory basis, the compensation paid to our named executive officers. Proposal 4; Amendment of the Company’s By-Laws The votes cast to approve an amendment to the By-Laws of the Company to address the quorum requirements for an adjourned meeting of Shareholders as described in the our management information circular and proxy statement for the Annual Meeting were as follows: . For: 123,410,315 Against: 105,771,772 Broker Non-Vote 200,401,613 Accordingly, the stockholders approved the amendment to the By-Laws.